Os Therapies
Rockville, Maryland, United States · Biopharma, Biotechnology, Healthcare
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Rockville, Maryland, United States
- Employees
- 5
- Industries
- Biopharma, Biotechnology, Healthcare
- Status
- Public (OSTX)
- Website
- ostherapies.com
- Company page
Recent activity at Os Therapies
- : SEC 8-K (8.01): On November 11, 2026, OS Therapies UK Ltd., a subsidiary of OS Therapies Incorporated, received a VAT refund from HM Revenue and Customs amounting to £678,715.46 (approximately $900,000). This refund will be utilized to support the clinical development and regulatory readiness of their leading product candidate, Herlystic® (OST-HER2), aimed at preventing the recurrence of pulmonary metastatic osteosarcoma. Additionally, the FDA suspended its Commissioner’s National Priority Voucher program on November 12, 2026; however, this does not affect OS Therapies’ eligibility for the rare pediatric disease priority review voucher program. The developments signify a potential positive impact on the company's operations and strategic direction.
- : OS THERAPIES
- : SEC 8-K (1.01):
About Os Therapies: questions and answers
What does Os Therapies do?
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.
Where is Os Therapies headquartered?
Os Therapies is headquartered in Rockville, Maryland, United States.
How many employees does Os Therapies have?
Os Therapies has about 5 employees.
What is the latest news on Os Therapies?
On Nov 12, 2026, SEC 8-K (8.01): On November 11, 2026, OS Therapies UK Ltd., a subsidiary of OS Therapies Incorporated, received a VAT refund from HM Revenue and Customs amounting to £678,715.46 (approximately $900,000). This refund will be utilized to support the clinical development and regulatory readiness of the
Is Os Therapies a public company?
Yes. Os Therapies is publicly traded under the ticker OSTX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy